Cortisol And Growth Hormone
Mostrando 1-12 de 45 artigos, teses e dissertações.
-
1. Cushing disease due to a somatic USP8 mutation in a patient with evolving pituitary hormone deficiencies due to a germline GH1 splicing variant
SUMMARY We present the unique case of an adult Brazilian woman with severe short stature due to growth hormone deficiency with a heterozygous G to T substitution in the donor splice site of intron 3 of the growth hormone 1 (GH1) gene (c.291+1G>T). In this autosomal dominant form of growth hormone deficiency (type II), exon 3 skipping results in expression of
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
2. Is biochemical hypoglycemia necessary during an insulin tolerance test?
ABSTRACT Objective The insulin tolerance test (ITT) has been accepted as the gold standard test for assessing the integrity of the growth hormone (GH) – insulin-like growth factor (IGF-1) axis and the hypothalamic-pituitary-adrenal (HPA) axis. The goal of the test is to achieve clinical and biochemical hypoglycemia at a blood glucose level ≤ 40 mg/dL t
Arch. Endocrinol. Metab.. Publicado em: 2020-02
-
3. Live weight and metabolic hormone profile in steers moved in drives
The objective was to determine the effects of driving on the growth of steers during 55 days of moving by drive and 84 days after the arrival. Twenty-five steers were randomly chosen from a herd of 1,000 Nellore cattle, which were evaluated in two periods: the driving period, in which animals were moved a distance of 700 km on foot for 55 d; and the post-dri
R. Bras. Zootec.. Publicado em: 2014-10
-
4. Pituitary deficiency after aneurysmal subarachnoid hemorrhage
OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorr
Clinics. Publicado em: 2013-06
-
5. Papel da via lkaros-FGFR4 na evolução pós-cirúrgica dos pacientes com doença de Cushing / Ikaros-FGFR4 pathway: role in the postoperative outcome of Cushings disease
Introduction: The mechanisms involved in the molecular pathogenesis of corticotroph pituitary tumors are complex, heterogeneous and in most cases remain unknown. Changes in the expression of components of Ikaros (Ik) pathway, such as receptor 4 of fibroblast growth factor (FGFR4), have been detected in pituitary tumors including corticotropinomas. Imbalance
Publicado em: 2010
-
6. Resposta neuroendócrina aguda ao citalopram e resposta terapêutica no transtorno obsessivo-compulsivo / Acute neuroendocrine response to citalopram and therapeutic response in obsessive-compulsive disorder
INTRODUÇÃO: Testes provocativos com drogas serotonérgicas não apresentaram resultados consensuais em pacientes com TOC, sugerindo que a atividade serotonérgica seja heterogênea neste transtorno. É possível que a disfunção serotonérgica se relacione à resistência ao tratamento com inibidores de recaptura de serotonina (IRS) neste transtorno. O ob
Publicado em: 2007
-
7. Efeito de sessÃes de treinamento resistido sobre a concentraÃÃo hormonal de testosterona, cortisol e GH em idosas fisicamente ativas
IntroduÃÃo: Os efeitos do treinamento resistido sobre sÃntese / liberaÃÃo de hormÃnios demonstraram que os exercÃcios resistidos podem alterar as concentraÃÃes circulantes de hormÃnios como os nÃveis de testosterona, cortisol e hormÃnio do crescimento alterando as concentraÃÃes plasmÃticas destes hormÃnios. Objetivo: O propÃsito deste estudo
Publicado em: 2007
-
8. Thyroid and glucocorticoid hormones synergistically control growth hormone mRNA in cultured GH1 cells.
We have previously demonstrated that thyroid hormone controls growth hormone synthesis in GH1 cells and that the induction of the growth hormone response by glucocorticoid appears to be highly dependent on thyroid hormone action. Thyroid hormone induces growth hormone synthesis approximately 5- to 20-fold and cortisol increases this response 2- to 6-fold fur
-
9. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.
The effect of cyproheptadine on plasma growth hormone and cortisol levels was studied in seven male volunteers with polygraphic sleep monitoring. Sleep-related growth hormone release was completely inhibited in three of the seven normal subjects by the intravenous infusion of cyproheptadine (5 mg) which was started at the onset of sleep. In the other four, g
-
10. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man
The effect of administration of human growth hormone (HGH) (3 mg every 6 hr for 6 days) on the endogenous GH response to insulin-induced hypoglycemia at 8, 12, 24, and 48 hr posttreatment was studied in 11 healthy male adults. Free fatty acid, cortisol, and glucose responses pre- and posttreatment with HGH were evaluated concurrently. Control subjects receiv
-
11. Growth hormone secretion during sleep
Plasma growth hormone (GH), insulin, cortisol, and glucose were measured during sleep on 38 nights in eight young adults. Blood was drawn from an indwelling catheter at 30-min intervals; EEG and electrooculogram were recorded throughout the night. In seven subjects, a plasma GH peak (13-72 mμg/ml) lasting 1.5-3.5 hr appeared with the onset of deep sleep. Sm
-
12. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects.